Active participation in international conferences and symposiums (60)
  1. 12. De Fisenne, M.-A., Houben, S., Ando, K., Vanden Dries, V., Poncelet, L., Yilmaz, Z., Mansour, S., De Decker, R., Brion, J. P., & Leroy, K. (2021). Intravenous injection of PHF-tau proteins from Alzheimer brain exacerbates neuroinflammation, amyloid beta and tau pathologies in APP/PS1 transgenic mice. (p. 72) Abstract session presented at Poster presentation to the Third Eurotau meeting(October 25-26: Lille, France).
  2. 13. Kosa, A.-C., Ando, K., Lasri, H., Yilmaz, Z., Doeraene, E., López Gutiérrez, L., De Decker, R., De Fisenne, M.-A., Suain, V., Buée, L., Brion, J. P., & Leroy, K. (2021). Deletion of murine APP accelerates cognitive deficits in a murine model of amyloid and tau pathologies. (p. 88) Abstract session presented at Poster presentation to the Third Eurotau meeting(October 25-26: Lille, France).
  3. 14. López Gutiérrez, L., Kosa, A.-C., De Decker, R., Yilmaz, Z., Suain, V., Brion, J. P., Ando, K., & Leroy, K. (2021). Comparison of tau seeding activities between Alzheimer disease and FTLD- MAPT-G335A mutation. (p. 96) Abstract session presented at Poster presentation to the Third Eurotau meeting(October 25-26: Lille, France).
  4. 15. López Gutiérrez, L., Kosa, A.-C., De Decker, R., Yilmaz, Z., Suain, V., Brion, J. P., Ando, K., & Leroy, K. (2021). Comparison of tau seeding activities between Alzheimer disease and FTLD-MAPT-G335A mutation. (p. 136) Abstract session presented at New Horizons in Alzheimer’s Disease(October 27-28, 2021: Leuven, Belgium).
  5. 16. Brion, J. P. (2020). Maladie d'Alzheimer: aspects historiques et défis actuels de la recherche. Paper session presented at Journée Scientifique Francophone du CALM (Club Alzheimer de Montpellier) (WEB-Conference: 17 et 18/11 2020: Montpellier).
  6. 17. Brion, J. P. (2020). Tau Research: History and Current Challenges: Plenary Lecture. Paper session presented at Tau2020 Global Conference. (Organized by the Rainwater Foundation, CurePSP, and the Alzheimer Association (USA): Feb 12-13, 2020: Washington,DC, USA).
  7. 18. Ando, K., Pregoni, G., Verheijen, J., Vergara Panos, C., De Decker, R., Mansour, S., Yilmaz, Z., Suain, V., Dauphinot, L., Fontaine, G., Leroy, K., Duyckaerts, C., Sleegers, K., Potier, M.-C., & Brion, J. P. (2019). Picalm susceptibility RS3851179 locus for late onset Alzheimer's disease affects the levels of its mRNA and protein expression in human. Abstract session presented at 14th conference of Alzheimer and Parkinson's diseases (ADPD)(26-31 march 2019: Lisbon, Portugal)
  8. 19. Poncelet, L., Ando, K., Vergara Panos, C., Gilissen, E., Yilmaz, Z., Mansour, S., Brion, J. P., & Leroy, K. (2019). Aged cats: a naturally occuring model of tauopathy. Abstract session presented at 14th conference of Alzheimer and Parkinson's diseases (ADPD)(26-31 march 2019: Lisbon, Portugal)
  9. 20. Vergara Panos, C., Houben, S., Suain, V., Yilmaz, Z., De Decker, R., Vanden Dries, V., Mansour, S., Boom, A., Ando, K., Brion, J. P., & Leroy, K. (2019). Amyloid pathology enhances seeding and propagation of fibrillar endogenous non-mutant tau in vivo through p25/CDK5 activation. Paper session presented at 14th conference of Alzheimer and Parkinson's diseases (ADPD) (26-31 march 2019: Lisbon, Portugal).
  10. 21. Pierrot, N., Ris, L., Stancu, I.-C., Doshina, A., Ribeiro, F., Tyteca, D., Bauge, E., Lalloyer, F., Malong, L., Schakman, O., Leroy, K., Kienlen-Campard, P. K., Gailly, P., Brion, J. P., Dewachter, I., Staels, B., & Octave, J. N. (2019). Gender specific improvement of synaptic function by activation of RXR nuclear receptor is mediated by PPAR alpha. Paper session presented at 14th conference of Alzheimer and Parkinson's diseases (ADPD) (26-31 march 2019: Lisbon, Portugal).
  11. 22. Brion, J. P., Vergara Panos, C., Houben, S., Suain, V., Yilmaz, Z., De Decker, R., Boom, A., Mansour, S., Buée, L., Vanden Dries, V., Ando, K., & Leroy, K. (2019). Tau pathology propagation in mice models induced by native human Alzheimer PHF. Abstracts of the Conference Abstract session presented at Oral presentation to the "14th conference of Alzheimer and Parkinson's diseases (ADPD)"(26-31 march 2019: Lisbon, Portugal)
  12. 23. Ando, K., Ndjim, M., Pregoni, G., Dauphinot, L., Fontaine, G., Yilmaz, Z., Suain, V., De Decker, R., Authelet, M., Delatour, B., Duyckaerts, C., Brion, J. P., & Potier, M.-C. (2018). The presynaptic lipid phosphatase Synaptojanin1 shows increased insolubility in Alzheimer brains, is localized with Hirano bodies and accumulated in plaque-associated dystrophic neurites. Paper session presented at 7eme Rencontres Scientifiques et cliniques (Fondation Alzheimer). (7: 05 December 2018: Paris, France).
    13. << Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Next >>